Aspira Pathlab & Diagnostics L Share Price

₹ 130.00

-₹3.80 (-2.84%)
1D
Last updated 02 Nov, 2026, 15:27 IST

Aspira Pathlab & Diagnostics L Share Price Today

As of 2 Nov 2026, Aspira Pathlab & Diagnostics L share price is ₹130.00. The stock opened at ₹133.80, compared to its previous close of ₹133.80. During today's trading session, Aspira Pathlab & Diagnostics L share price moved in the range of ₹130.00 to ₹140.45, with an average price of ₹135.22 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.00 and a high of ₹149.99.

Share price over the last 1 day fell from 140.45 to 130.00, ranging between 130.00 and 140.45.
₹130.00
2.84% down today
₹140.45
1D LOW
1D HIGH

Aspira Pathlab & Diagnostics L Stock Insights

Latest Earning
Op Profit TrendUp by 175.66% YoY
Latest Earning
Net Profit TrendUp by 175.66% YoY
Latest Earning
Revenue TrendUp by 64.39% YoY
Stock Performance
OutperformingBeat Nifty by 18.71 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 0.13%
Aspira Pathlab & Diagnostics L stock performance
Open₹133.80
High₹140.45
Low₹130.00
Prev. close₹133.80
Aspira Pathlab & Diagnostics L trading activity
Volume1,376
Average traded price₹133.19
Last traded time03:27:32 02 Nov
Last traded quantity250
Circuit
L
H
₹127.15
₹140.45
52-week
L
H
₹49.00
₹149.99
Mkt Cap Cr
137.72
P/E
57.42
P/B
19.03
ROA
13.75%
ROE
16.62%
ROCE
13.17%
Quick Ratio
2.05
EV/EBITDA
35.46

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Aspira Pathlab performance is moderate compared to markets
Valuation: 3 out of 5, Fairly Valued
Valuation
Fairly Valued
Aspira Pathlab appears to be fairly valued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Aspira Pathlab earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,20,779.1155.6112.749.79%20.48%17.27%0.9830.42
MANIPAL HEALTH ENTERPRI L87,926.3997.025.354.07%10.59%9.51%1.1734.66
Max Healthcare83,704.6860.657.397.37%12.18%13.24%0.8433.68
Aster DM Healthcare59,570.09164.2814.164.47%8.48%10.1%1.966.59
Fortis Healthcare58,116.6854.295.876.7%10.53%12.56%0.828.03
Narayana Hrudayalaya35,143.9343.047.746.43%17.17%12.26%2.0719.68
Global Health34,121.9061.788.619.35%14.05%15.26%2.5432.32
Dr. Lal Path Labs31,997.0258.5712.7617.36%20.13%25.56%3.3834.28
KRISHNA INST OF MED SCI L29,480.26151.67.872.51%10.74%7.99%0.6839.1
Syngene International16,251.7287.333.342.79%5.47%7.06%1.2922.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aspira Pathlab & Diagnostics L Company Background

ISIN
INE500C01017
Sector Market Cap
₹ 137.72 Cr

Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.

Aspira Pathlab & Diagnostics L Financial Highlights

  • Revenue: Aspira Pathlab & Diagnostics L reported revenue of ₹22.39 crore in FY25 vs ₹13.62 crore in FY24. It showed an increase of 64.39% on a yearly basis.
  • Operating Profit: Aspira Pathlab & Diagnostics L reported an operating profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a year-on-year basis.
  • Net Profit: Aspira Pathlab & Diagnostics L reported a net profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a yearly basis.

Aspira Pathlab & Diagnostics L Quarterly Result Highlights

  • Aspira Pathlab & Diagnostics L reported revenue of ₹5.36 crore in Jun 2025, compared with ₹5.91 crore in Mar 2025, representing a decrease of 9.31% on a quarter-on-quarter (QoQ) basis.
  • Aspira Pathlab & Diagnostics L reported an operating profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, representing a decrease of 38.24% on a quarter-on-quarter (QoQ) basis.
  • Aspira Pathlab & Diagnostics L reported a profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, reflecting a decrease of 38.24% on a QoQ basis.
  • The earnings per share (EPS) of Aspira Pathlab & Diagnostics L stood at ₹1.97 during Jun 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
46.65%
FII
0.00%
Other DII
0.00%
Retail and other
53.35%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Aspira Pathlab & Diagnostics L Investment Returns

1 day
+4.98%
1 week
+6.15%
1 month
-2.89%
1 year
+112.38%
3 years
+256.80%
5 years
+65.80%

Aspira Pathlab & Diagnostics L Share Price History

Aspira Pathlab & Diagnostics L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹127.45 / ₹133.80
+4.98%
29 Oct 26
₹119.40 / ₹127.45
+1.43%
28 Oct 26
₹118.75 / ₹125.65
+0.52%
27 Oct 26
₹125.00 / ₹125.00
-0.40%
Show more

Aspira Pathlab & Diagnostics L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹22.00₹13.20
Other Income₹0.39₹0.42
Total Revenue₹22.39₹13.63
Total Expenses₹20.32₹16.30
Profit Before Tax₹2.02-₹2.67
Tax₹0.00₹0.00
Profit After Tax₹2.02-₹2.67
EPS - Basic₹1.97-₹2.60
EPS - Diluted₹1.97-₹2.60

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹2.02-₹2.67
Income before WC changes₹3.80-₹0.90
Change in Assets-₹2.29₹1.45
Change in Liabilities₹0.32₹0.51
Change in WC-₹1.97₹1.96
Cash flow from Operations₹1.83₹1.05
Cash flow from Investing₹0.12₹0.14
Cash flow from Financing-₹0.99-₹0.95
Total Cash Flow₹0.95₹0.24
Cash (Start of the year)₹0.80₹0.57
Cash (End of the year)₹1.75₹0.80

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹12.10₹10.35
Current Assets₹5.36₹4.36
Total Assets₹17.46₹14.71
Current Liabilities₹2.37₹2.07
Net Current Asset₹2.99₹2.28
Non-Current Liabilities₹2.92₹2.50
Equity Capital₹12.17₹10.14
Total Equity & Liabilities₹17.46₹14.71

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹24.98₹22.00₹13.20₹14.46
Other Income₹0.52₹0.39₹0.42₹0.32
Total Revenue₹25.50₹22.39₹13.63₹14.78
Total Expenses₹25.45₹20.32₹16.30₹14.87
Profit Before Tax₹0.05₹2.07-₹2.67-₹0.09
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹0.05₹2.07-₹2.67-₹0.09
EPS - Basic₹0.05₹2.01-₹2.60-₹0.09
EPS - Diluted₹0.05₹2.01-₹2.60-₹0.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.05₹2.07-₹2.67-₹0.09
Income before WC changes₹1.87₹3.85-₹0.90₹1.71
Change in Assets-₹1.27-₹2.29₹1.45-₹1.59
Change in Liabilities₹0.85₹0.32₹0.51-₹0.14
Change in WC-₹0.41-₹1.97₹1.96-₹1.73
Cash flow from Operations₹1.45₹1.88₹1.05-₹0.01
Cash flow from Investing-₹0.80₹0.07₹0.14₹0.16
Cash flow from Financing-₹1.14-₹0.99-₹0.95-₹0.94
Total Cash Flow-₹0.49₹0.95₹0.24-₹0.79
Cash (Start of the year)₹1.75₹0.80₹0.57₹1.35
Cash (End of the year)₹1.26₹1.75₹0.80₹0.57

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹13.92₹12.15₹10.35₹11.49
Current Assets₹4.59₹5.36₹4.36₹5.86
Total Assets₹18.51₹17.51₹14.71₹17.34
Current Liabilities₹3.11₹2.37₹2.07₹1.58
Net Current Asset₹1.47₹2.99₹2.28₹4.27
Non-Current Liabilities₹3.16₹2.92₹2.50₹3.01
Equity Capital₹12.23₹12.22₹10.14₹12.75
Total Equity & Liabilities₹18.51₹17.51₹14.71₹17.34
* All values are in INR Crore
Aspira Pathlab & Diagnostics L market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Aspira Pathlab & Diagnostics L technical summary
Bearish indicators4
Neutral indicators2
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
63.63
Neutral
ATR (14)
9.11
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
17.68
Bullish
UO(9)
72.54
Bearish
ROC(12)
16.65
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
127.48
128.2
10D
124.31
125.41
20D
120.96
122.47
50D
111.39
116.06
100D
111.43
108.43
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Aspira Pathlab & Diagnostics L
Healthcare Services
Add Stock
Add Another

Aspira Pathlab & Diagnostics L Share Price FAQs

Please be aware that Aspira Pathlab & Diagnostics L stock prices are subject to continuous fluctuations due to various factors.